Back
EyePoint Pharmaceuticals Stock Price Chart
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
35
EYPT
EyePoint Pharmaceuticals
Last Price:
$5.92
Seasonality Move:
2.04%
7 Day Trial
ALL ACCESS PASS
$
7
The key to a $1.3T opportunity
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EYPT is experiencing selling pressure, which indicates risk of future bearish movement.
EyePoint Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 6.42 | Sell |
| 20-day SMA: | 6.31 | Sell |
| 50-day SMA: | 6.09 | Sell |
| 200-day SMA: | 7.96 | Sell |
| 8-day EMA: | 6.2 | Sell |
| 20-day EMA: | 6.21 | Sell |
| 50-day EMA: | 6.26 | Sell |
| 200-day EMA: | 8.2 | Sell |
EyePoint Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.07 | Buy |
| Relative Strength Index (14 RSI): | 44.88 | Sell |
| Chaikin Money Flow: | -451558 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (5.18 - 6.8) | Sell |
| Bollinger Bands (100): | (5.68 - 7.74) | Sell |
EyePoint Pharmaceuticals Technical Analysis
| Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for EyePoint Pharmaceuticals Stock
Is EyePoint Pharmaceuticals Stock a Buy?
-
EyePoint Pharmaceuticals share price is 5.85 while EYPT 8-day simple moving average is 6.42, which is a Sell signal.
-
The stock price of EYPT is 5.85 while EyePoint Pharmaceuticals 20-day SMA is 6.31, which makes it a Sell.
-
EyePoint Pharmaceuticals 50-day simple moving average is 6.09 while EYPT share price is 5.85, making it a Sell technically.
-
EYPT stock price is 5.85 and EyePoint Pharmaceuticals 200-day simple moving average is 7.96, creating a Sell signal.
EYPT Technical Analysis vs Fundamental Analysis
Sell
35
EyePoint Pharmaceuticals (EYPT)
is a Sell
Is EyePoint Pharmaceuticals a Buy or a Sell?
-
EyePoint Pharmaceuticals stock is rated a SellThe current EyePoint Pharmaceuticals [EYPT] share price is $5.85. The Score for EYPT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
EyePoint Pharmaceuticals Stock Info
Market Cap:
402.5M
Price in USD:
5.85
Share Volume:
529.6K
EyePoint Pharmaceuticals 52-Week Range
52-Week High:
13.99
52-Week Low:
3.91
Sell
35
EyePoint Pharmaceuticals (EYPT)
is a Sell
EyePoint Pharmaceuticals Share Price Forecast
-
What is the EyePoint Pharmaceuticals stock price today?The EyePoint Pharmaceuticals stock price is 5.85 USD today.
-
Will EYPT stock go up or go down?EyePoint Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is EyePoint Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, EyePoint Pharmaceuticals is overvalued.
Is EyePoint Pharmaceuticals Stock a Buy?
-
EyePoint Pharmaceuticals share price is 5.85 while EYPT 8-day exponential moving average is 6.20, which is a Sell signal.
-
The stock price of EYPT is 5.85 while EyePoint Pharmaceuticals 20-day EMA is 6.21, which makes it a Sell.
-
EyePoint Pharmaceuticals 50-day exponential moving average is 6.26 while EYPT share price is 5.85, making it a Sell technically.
-
EYPT stock price is 5.85 and EyePoint Pharmaceuticals 200-day simple moving average is 8.20, creating a Sell signal.
Fundamental Analysis of EyePoint Pharmaceuticals
Is EyePoint Pharmaceuticals a good investment?
-
Analysts estimate an earnings increase this quarter of $0.25 per share, an increase next quarter of $0.14 per share, an increase this year of $0.11 per share, and a decrease next year of $0.90 per share.
Technical Analysis of EyePoint Pharmaceuticals
Should I short EyePoint Pharmaceuticals stock?
-
EYPT Moving Average Covergence Divergence (MACD) indicator is 0.07, suggesting EyePoint Pharmaceuticals is a Buy
-
EyePoint Pharmaceuticals Relative Strength Index (RSI) is 44.88, which suggest EyePoint Pharmaceuticals is oversold
-
The Bollinger Bands (25) for EyePoint Pharmaceuticals is (5.18 - 6.8), which suggest EyePoint Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for EyePoint Pharmaceuticals is (5.68 - 7.74), which suggest EyePoint Pharmaceuticals is a Sell
* EyePoint Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.